Matinas Biopharma Holdings Inc (AMEX:MTNB) does about 994.12K shares in volume on a normal day but saw 22150686 shares change hands in Friday trading. The company now has a market cap of 60.40M USD. Its current market price is $0.28, marking an increase of 4.43% compared to the previous close of $0.27. The 52 week high reached by this stock is $0.89 whilst the lowest price level in 52 weeks is $0.11.
Matinas Biopharma Holdings Inc (MTNB) has a 20-day trading average at $0.2708 and the current price is -68.76% off the 52-week high compared with 152.04% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2358 and its 200-day simple moving average is $0.2466. If we look at the stock’s price movements over the week, volatility stands at 20.71%, which decreases to 13.19% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 55.39 to suggest the stock is neutral.
The consensus objective for the share price is $1.00, suggesting that the stock has a potential upside of 72.0% over the period.
Piper Sandler initiated its price target at $3.
Matinas Biopharma Holdings Inc (MTNB) stock is down -7.33% over the week and 24.66% over the past month. Its price is 28.58% year-to-date and -32.54% over the past year.
To reach the target analysts have set, the stock logically needs to grow 72.0 percent from here.
Outstanding shares total 217.26M with insiders holding 2.91% of the shares and institutional holders owning 12.05% of the company’s common stock. The company has a return on investment of -81.09% and return on equity of -68.85%. The beta has a value of 1.53. Price to book ratio is 2.61 and price to sales ratio is 27.96.
